Landmark Bio

About Landmark Bio

Landmark Bio is a cell and gene therapy manufacturing company dedicated to developing innovative technologies, products, and services to bridge the gap from research to patient treatment. They aim to support academic researchers, physician scientists, and biopharma leaders by removing obstacles, maximizing efficiency, and accelerating milestones in therapeutic development.

Products & Services

Process & Analytical Development:Services focused on developing and analyzing processes for therapy production.

Formulation Development:Development of formulations for therapeutic products.

Cell & Gene Therapy Manufacturing:Manufacturing services for cell and gene therapies.

Fill & Finish:Final filling and finishing services for therapeutic products.

Quality Control Testing:Testing services to ensure quality of therapeutic products.

CMC Regulatory & Drug Development Consulting:Consulting services for regulatory and drug development processes.

IND-Enabling Services:Services to support Investigational New Drug (IND) filings.

Viral Vectors:Technologies related to viral vector production for therapies.

Cell Therapies:Development and manufacturing of cell-based therapies.

Nucleic Acids:Focus on nucleic acid-based therapeutic technologies.

Extracellular Vesicles:Technologies involving extracellular vesicles for therapy.

Nanoparticles & Non-viral Delivery:Development of nanoparticle and non-viral delivery systems.

Specialties

Cell and Gene Therapy Manufacturing Advanced Therapy CDMO Viral Vectors Cell Therapies Nucleic Acids Extracellular Vesicles Nanoparticles & Non-viral Delivery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Government Grant T: - FT: Government Grant	A: 18300000 MR: - FA: up to $18.3 million FAN: 18300000	D: 2026-04-16 FD: 2026-04-16	1 investors
2	RT: Award T: - FT: Award	A: 18300000 MR: - FA: up to $18.3 million FAN: 18300000	D: 2026-04-01 FD: 2026-04-01	1 investors

Government Grant Latest

2026-04-16

$18.3M

1 investor (Pro only)

Award 2026-04-01

$18.3M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Gregg Nyberg

CHIEF TECHNOLOGY OFFICER

A

Amanda Owens

Senior Vice President, Commercial

E

Eli Kraus

Vice President, Process Development and Analytics

O

Olga Mollin

VICE PRESIDENT, TECHNICAL OPERATIONS & SITE HEAD

M

Michael Sousa

VICE PRESIDENT, QUALITY SITE HEAD

K

Kris Ward

VICE PRESIDENT, CORPORATE DEVELOPMENT & LICENSING

View 14 more team members with Pro

Unlock Full Team Directory

Recent News

Landmark Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised